| 31 Aug, 07:56 pm | kmp_change | 3 | Resignation of a Director/KMP/SMP (specific role not stated in the provided text). | nse |
| 31 Aug, 07:46 pm | kmp_change | 3 | Shri G.M. Naidu resigned from the position of Manufacturing/Sr. General Manager (Chief of Operations) effective August 31, 2026 due to personal commitments. | nse |
| 31 Aug, 07:44 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 29 Aug, 07:03 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for FY 2025-26'. | nse |
| 29 Aug, 03:00 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Reg. 34 (1) Annual Report. | bse |
| 17 Aug, 05:26 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange that Record date for the purpose of Dividend is 15-Sep-2026. | nse |
| 17 Aug, 04:30 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange about Transcript | nse |
| 17 Aug, 04:28 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 10 Aug, 09:39 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange about Link of Recording | nse |
| 10 Aug, 09:39 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 10 Aug, 01:18 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange about Investor Presentation | nse |
| 10 Aug, 01:16 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 07 Aug, 09:02 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange regarding Change in Director(s) of the company. | nse |
| 07 Aug, 09:01 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 07 Aug, 08:28 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange regarding 'Capacity Addition'. | nse |
| 07 Aug, 08:16 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Approved Capacity Addition For Development Of Intermediate Block | bse |
| 07 Aug, 08:05 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange regarding Change in Director(s) of the company. | nse |
| 07 Aug, 08:03 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 07 Aug, 07:59 pm | — | … | Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. | nse |
| 07 Aug, 07:56 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Approval Of Unaudited Financial Results (Standalone And Consolidated)For The Quarter Ended June 30, 2026 | bse |
| 07 Aug, 07:47 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Board Meeting Outcome for Outcome Of Board Meeting Held On August 07, 2026. | bse |
| 28 Jul, 10:47 am | — | … | Aarti Pharmalabs Ltd - 543748 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30, 2026. | bse |
| 30 Jun, 05:56 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange regarding a press release dated Jun 30, 2026, titled Aarti Pharmalabs Limited inaugurates its new state-of-the-art additional manufacturing block at Tarapur Unit 5, Maharashtra to expand its production capacity. | nse |
| 30 Jun, 05:46 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 24 Jun, 10:23 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange regarding allotment of 22062 securities pursuant to ESOP/ESPS at its meeting held on Jun 24, 2026 | nse |
| 22 Jun, 04:05 pm | — | … | Chandrakant Vallabhaji Gogri has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | nse |
| 12 Jun, 02:53 pm | procedural | 0 | Chandrakant Vallabhaji Gogri submitted a copy of a disclosure under SEBI Takeover Regulations (Reg 31(4)) for substantial acquisition/shareholding purposes. | nse |
| 01 Jun, 05:14 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange about Transcript | nse |
| 01 Jun, 05:09 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 26 May, 10:17 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange about Link of Recording | nse |
| 26 May, 10:14 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 26 May, 04:45 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Compliances-Reg.24(A)-Annual Secretarial Compliance | bse |
| 26 May, 02:40 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange about Investor Presentation | nse |
| 26 May, 02:39 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 26 May, 01:23 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Audited Financial Results For The Quarter And Financial Year Ended March 31, 2026 | bse |
| 25 May, 09:27 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange about change in Management | nse |
| 25 May, 09:24 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 25 May, 09:19 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Grant Of Options Under 'APL Performance Stock Option Plan- 2023' | bse |
| 25 May, 09:15 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange about Re-appointment of Cost Auditor & Internal Auditor for FY 2026-2027 | nse |
| 25 May, 09:11 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Corporate Action-Board to consider Dividend | bse |
| 25 May, 09:08 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange that Board of Directors at its meeting held on May 25, 2026, recommended Final Dividend of Rs. 2 per equity share. | nse |
| 25 May, 09:07 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Board Meeting Outcome for Approval Of Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended On 31 March 2026 And Recommending Final Dividend. | bse |
| 25 May, 09:03 pm | — | … | Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | nse |
| 14 May, 11:26 am | — | … | Aarti Pharmalabs Ltd - 543748 - Update on board meeting | bse |
| 11 May, 03:09 pm | — | … | Aarti Pharmalabs Ltd - 543748 - Board Meeting Intimation for Approval Of The Audited Financial Results For The Quarter And Financial Year Ended March 31, 2026 And Recommendation Of Final Dividend, If Any. | bse |
| 04 Apr, 04:59 pm | — | … | Aarti Pharmalabs Limited has informed the Exchange regarding ' Intimation Regarding Second 100-Day Campaign - ''Saksham Niveshak''. | nse |
| 04 Apr, 10:24 am | — | … | Aarti Pharmalabs Ltd - 543748 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011. | bse |
| 04 Apr, 10:22 am | — | … | Aarti Pharmalabs Ltd - 543748 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011. | bse |
| 04 Apr, 10:17 am | — | … | Aarti Pharmalabs Ltd - 543748 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | bse |
| 04 Apr, 10:17 am | — | … | Aarti Pharmalabs Ltd - 543748 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | bse |